DUBLIN, March 30, 2021 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved a revised label for Vyxeos® (daunorubicin and cytarabine) to include...
The Podcast by KevinMD | Podcast | October 6, 2020 “As I read about Dr. Breen, saddened by the fact that we have been robbed of...